Emerging markets present significant growth opportunities for the Dry Age-Related Macular Degeneration Market, driven by increasing healthcare expenditure and improvements in diagnostic infrastructure. Countries in Asia-Pacific, Latin America, and the Middle East are witnessing a rise in dry AMD cases, supported by growing geriatric populations and urbanization-related lifestyle changes.
Governments in these regions are prioritizing eye health through national screening programs and subsidies for treatment, enhancing accessibility for patients. Additionally, international collaborations and investments are facilitating technology transfer and capacity building. These developments are propelling the Dry Age-Related Macular Degeneration Market in emerging economies, contributing significantly to global market growth.